#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelofibrosis Thalassaemia beta Transitional cell carcinoma Prostate cancer Metachromatic leukodystrophy Head and neck cancer Chondrosarcoma Cutaneous T-cell lymphoma refractory Cold type haemolytic anaemia Pyruvate dehydrogenase complex deficiency Cardiac sarcoidosis Chronic lymphocytic leukaemia Staphylococcal infection Neurodegenerative disorder Hypersomnia More trials…

    Learn about Rare Diseases

    Chordoma – Basic Information Leiomyosarcoma – Trials in Disease Mastocytosis – Basic Information Alport’s syndrome – Trials in Disease Krabbe’s disease – Diagnostics Hairy cell leukaemia – Basic Information Angelman’s syndrome – Life with Disease Wolfram syndrome – Diagnostics Usher’s syndrome – Basic Information Myelodysplastic syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iph6501 Sphingomyelin (Egg) Ngi226 Omp64 PIROXICAM IG-TREGS Relugolix Cyanocobalamin Atomoxetine Camlipixant Desvenlafaxine Benzoate Incb099280 Filgotinib ANX007 Serine Cefoxitin Sparsentan Mitoxantrone Hydrochloride Tramadol Epinephrine More therapies…

    Learn about Your Condition

    Osteosarcoma metastatic Blood iron increased Hepatitis B Breast cancer female Gaucher's disease type I Tachypnoea Brain neoplasm Metabolic surgery Keratosis follicular External cephalic version Ovarian granulosa cell tumour Glomerulonephritis chronic Haemorrhoids Palmoplantar pustulosis Brain neoplasm malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study of Tildrakizumab for Eye Problems in Patients with Lyell Syndrome

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Toxic epidermal necrolysis
    Investigated Drugs:
    • Tildrakizumab
    France

  • A Study of Isosorbide Mononitrate for Patients with Normal Tension Glaucoma to Improve Blood Flow to the Optic Nerve

    Not yet recruiting

    3 1 1
    Finland

  • A Study Comparing Tacrolimus and Ciclosporin Eye Drops for Children and Adults with Moderate to Severe Vernal Keratoconjunctivitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Tacrolimus Monohydrate
    • Ciclosporin
    Bulgaria France Greece Italy Spain

  • Study Using Gallium-68 FAPI PET/MRI Imaging to Measure Disease Activity in Patients with Graves’ Eye Disease

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands

  • Safety and early effectiveness study of VG801 subretinal injection in patients with ABCA4 mutation-associated retinal dystrophy

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • VG801-1
    • VG801-2
    Germany

  • Evaluation of Mesenchymal Stem Cell Eye Injections for Dry Eye Disease in Patients with Graft-versus-Host Disease Who Haven’t Responded to Standard Treatments

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Allogeneic Adipose-Derived Adult Mesenchymal Stem Cells Expanded
    Spain
Previous Page
1 … 13 14 15 16 17 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!